| Dr Nehal Mohammed Aleemuddin, MD | |
|
176 N Main St, Shavertown, PA 18708-1121 | |
| (570) 675-0900 | |
| (570) 674-9814 |
| Full Name | Dr Nehal Mohammed Aleemuddin |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 176 N Main St, Shavertown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518321082 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD468385 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Homebound Health Services Inc | Shavertown, PA | Home health agency |
| Commonwealth Home Health & Hospice Of Wilkes-barre | Forty fort, PA | Home health agency |
| Wilkes-barre General Hospital | Wilkes-barre, PA | Hospital |
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steffie Enterprises, Inc | 0840225736 | 354 |
| Commonwealth Physician Network Llc | 2668696592 | 84 |
News Archive
A protein that regulates cell differentiation in normal tissue may play a different role in colon and breast cancer, activating proliferation of damaged cells, according to researchers at the University of Illinois at Chicago College of Medicine.
The U.S. Department of State became an official partner of Together for Girls the global partnership to end sexual violence against girls announced last year by President William J. Clinton at the Annual Meeting of the Clinton Global Initiative.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.
Ritter Pharmaceuticals, a company dedicated to helping individuals live a healthier and happier life style through improved digestion, announced today that it will join the leading lactose intolerance experts around the country at the NIH Consensus Development Conference for Lactose Intolerance and Health in Bethesda, Maryland from February 22-24.
› Verified 1 days ago
| Entity Name | Commonwealth Physician Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003238635 PECOS PAC ID: 2668696592 Enrollment ID: O20140617000549 |
News Archive
A protein that regulates cell differentiation in normal tissue may play a different role in colon and breast cancer, activating proliferation of damaged cells, according to researchers at the University of Illinois at Chicago College of Medicine.
The U.S. Department of State became an official partner of Together for Girls the global partnership to end sexual violence against girls announced last year by President William J. Clinton at the Annual Meeting of the Clinton Global Initiative.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.
Ritter Pharmaceuticals, a company dedicated to helping individuals live a healthier and happier life style through improved digestion, announced today that it will join the leading lactose intolerance experts around the country at the NIH Consensus Development Conference for Lactose Intolerance and Health in Bethesda, Maryland from February 22-24.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nehal Mohammed Aleemuddin, MD 176 N Main St, Shavertown, PA 18708-1121 Ph: (570) 675-0900 | Dr Nehal Mohammed Aleemuddin, MD 176 N Main St, Shavertown, PA 18708-1121 Ph: (570) 675-0900 |
News Archive
A protein that regulates cell differentiation in normal tissue may play a different role in colon and breast cancer, activating proliferation of damaged cells, according to researchers at the University of Illinois at Chicago College of Medicine.
The U.S. Department of State became an official partner of Together for Girls the global partnership to end sexual violence against girls announced last year by President William J. Clinton at the Annual Meeting of the Clinton Global Initiative.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.
Ritter Pharmaceuticals, a company dedicated to helping individuals live a healthier and happier life style through improved digestion, announced today that it will join the leading lactose intolerance experts around the country at the NIH Consensus Development Conference for Lactose Intolerance and Health in Bethesda, Maryland from February 22-24.
› Verified 1 days ago
Dr. Michelle Jeena Im, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 176 N Main St, Shavertown, PA 18708 Phone: 570-675-0900 | |
Dr. Debra Thompson Miller, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Ivy Dr, Shavertown, PA 18708 Phone: 570-696-4767 | |
Devin Carey, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 176 N Main St, Shavertown, PA 18708 Phone: 570-675-0900 | |
Dr. Michael Vito Brown, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 176 N Main St, Shavertown, PA 18708 Phone: 570-675-0900 | |
Dr. Essam M Almeky, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 176 N Main St, Shavertown, PA 18708 Phone: 570-675-0900 Fax: 570-674-8912 | |
Krishnakant A Patel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 176 N Main St, Shavertown, PA 18708 Phone: 570-675-0900 Fax: 570-674-8912 |